AXIM BIOTECHNOLOGIES, INC. reports

Company location: San Diego, CA
Fiscal year end: 31 December

AXIM BIOTECHNOLOGIES, INC. has filed 306 SEC EDGAR filings since 10 Mar 2011

Filter by type:
10-K
10-Q
8-K
SC13D

SEC filing history

Showing 26-50 of 306 matching filings.

Per page

25

Current page

2

PRE 14C File 000-54296

SCHEDULE 14C INFORMATION

Filing date: 31 Aug 2023
Reporting date: 30 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-54296

AXIM BIOTECHNOLOGIES FORM 10-Q

Filing date: 21 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-Q File 000-54296

AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q

Filing date: 14 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-272390

EFFECT filing

Filing date: 09 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 07 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 07 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-1 File 333-272390

FORM S-1

Filing date: 02 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-54296

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filing date: 02 Jun 2023
Reporting date: 01 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-54296

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filing date: 30 May 2023
Reporting date: 23 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 30 May 2023
Reporting date: 23 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-54296

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filing date: 25 May 2023
Reporting date: 23 May 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 000-54296

FORM 10-Q

Filing date: 22 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-Q File 000-54296

AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q

Filing date: 15 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 000-54296

FORM 10-K

Filing date: 17 Apr 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

NT 10-K File 000-54296

AXIM BIOTECHNOLOGIES, INC. - NT 10K

Filing date: 31 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-54296

AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Filing date: 27 Jan 2023
Reporting date: 23 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q/A File 000-54296

FORM 10-Q/A

Filing date: 15 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 000-54296

FORM 10-Q

Filing date: 14 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

144 File 000-54296

144 filing

Filing date: 07 Oct 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 10 Dec 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 23 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Sep 2022
Reporting date: 13 May 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .